跳至主要内容
临床试验/NCT00765934
NCT00765934已完成不适用

Does Rapydan Influence Routine Clinical Chemistry and Hematology Measurements?

LabNoord1 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2009年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
25
试验地点
1
主要终点
Routine Clinical Chemistry measurements differences

研究概览

简要总结

There is an increasing awareness of the importance of treating procedure-related pain. Patients undergoing vascular access procedures are often afraid of needles and the discomfort associated with injections. This type of pain and/or fear can be stressful to patients. [1] For prevention of the pain associated with these procedures, the hospital is using Rapydan plasters. Rapydan consists out of two local anesthetics: lidocaine and tetracaïne. Rapydan produces topical anesthesia after an application time of 30 minutes and is used in the Martini Hospital for pain relieve by venipuncture and IV cannulation. The venous blood draining the anaesthetized skin contains a higher blood concentration of the local anesthetics than does venous blood in other parts of the body [2] Although the concentrations of the local anesthetics are low in patients with normal skin, the question is whether the presence of the local anesthetics which Rapydan contains might influence routine measurements in clinical chemistry and hematology.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
20 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Volunteers 20-60 years who are decision making competent

排除标准

  • Patients with local anesthetic allergy Patients using antiarrhythmic drugs Patients using other local anesthetics

研究组 & 干预措施

Rapydan

Other

Internal control. Blood from both arms will be drawn. Only one arm of the subject is treated with Rapydan.

干预措施: Rapydan (Drug)

结局指标

主要结局

Routine Clinical Chemistry measurements differences

时间窗: 1

次要结局

未报告次要终点

研究者

发起方
LabNoord
申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Influence of Rapydan on Clinical Chemistry and... | 临床试验